Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Booster Vaccine Strategy to Improve Serologic Responses to Influenza Vaccination in Children With Rheumatic Diseases and Inflammatory Bowel Disease Who Are Receiving Immunosuppressive Therapies

NCT03277703 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT03277703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03277703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Booster Vaccine Strategy to Improve Serologic Responses to Influenza Vaccination in Children With Rheumatic Diseases and Inflammatory Bowel Disease Who Are Receiving Immunosuppressive Therapies
Lead sponsor
Stony Brook University
Phase
Phase 2
Overall status
Completed
Start date
November 3, 2017
Completion date
December 30, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune complex diseases, inflammatory bowel diseases, rheumatologic disorder